Veterinary Medicine Information website

STREPTOMYCIN/ANAFASIS (125+125) MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ

Authorised
  • Streptomycin sulfate
  • Dihydrostreptomycin sulfate
Download as PDF

Product identification

Medicine name:
STREPTOMYCIN/ANAFASIS (125+125) MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
  • Streptomycin sulfate
  • Dihydrostreptomycin sulfate
Target species:
  • Cat
  • Dog
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Streptomycin sulfate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dihydrostreptomycin sulfate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cat
      • Not applicable
        no withdrawal period
    • Dog
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01GA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Uplab Pharmaceutical Company Ltd.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 80454/22-07-2022/K-0210201
Date of authorisation status change: